BCBeatrice H. Clark

Beatrice H. Clark

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Beatrice H. Clark has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Anita Gola

    Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Colin J. Chu

    Academic Unit of Ophthalmology, Translational Health Sciences, University of Bristol, Bristol, United Kingdom

    1 shared publication
  • Emily Speranza

    Florida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port Saint Lucie, FL, USA

    1 shared publication
  • Federica La Russa

    Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication
  • Hiroshi Ichise

    Lymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH

    1 shared publication
  • Ronald N. Germain

    Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

    1 shared publication

Latest Publications

  • Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection

    by Hiroshi Ichise, Emily Speranza, Federica La Russa, Tibor Z. Veres, Colin J. Chu, Anita Gola, Beatrice H. Clark, Ronald N. Germain

    Maintaining tissue function while eliminating infected cells is fundamental, and inflammatory damage plays a major contribution to lethality after lung infection. We tested 50 immunomodulatory regimes to determine their ability to protect mice from lethal infection. Only neutrophil depletion soon after infection prevented death from influenza. This result suggests that the infected host passed an early tipping point after which limiting innate damage alone could not rescue lung function. We investigated treatments that could have efficacy when administered later in infection. We found that partial limitation of viral spread together with enhancement of epithelial repair, by interferon blockade or limiting CD8 + T cell–mediated killing of epithelial cells, reduced lethality. This finding highlights the importance of rebalancing repair and damage processes in the survival of pulmonary infections.